| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/RME.12.5 |
| P8608 | Fatcat ID | release_o7i5go5wkjbyhak23ryb32pqvu |
| P698 | PubMed publication ID | 22397612 |
| P50 | author | Peter Ponsaerts | Q37831161 |
| Annemie Van der Linden | Q51729679 | ||
| Zwi N Berneman | Q79741950 | ||
| P2093 | author name string | Jasmijn Daans | |
| Jelle Praet | |||
| Kristien Reekmans | |||
| Nathalie De Vocht | |||
| P2860 | cites work | Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient | Q21090134 |
| Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect | Q24635138 | ||
| Axonal transection in the lesions of multiple sclerosis | Q29615585 | ||
| Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6 | Q29620590 | ||
| Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis | Q33185345 | ||
| TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis | Q33281667 | ||
| Plasmid-based genetic modification of human bone marrow-derived stromal cells: analysis of cell survival and transgene expression after transplantation in rat spinal cord. | Q33310220 | ||
| Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. | Q33367115 | ||
| Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner | Q33438830 | ||
| Immune regulatory neural stem/precursor cells protect from central nervous system autoimmunity by restraining dendritic cell function | Q33471488 | ||
| The level of B7 homologue 1 expression on brain DC is decisive for CD8 Treg cell recruitment into the CNS during EAE. | Q33930800 | ||
| Vasoactive intestinal peptide induces regulatory dendritic cells with therapeutic effects on autoimmune disorders. | Q34015933 | ||
| Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study | Q34132522 | ||
| High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis | Q34237823 | ||
| Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. | Q34433743 | ||
| Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis | Q34564111 | ||
| The mesenchymal stem cells in multiple sclerosis (MSCIMS) trial protocol and baseline cohort characteristics: an open-label pre-test: post-test study with blinded outcome assessments | Q34686955 | ||
| Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study | Q34934840 | ||
| Autologous haematopoietic stem-cell transplantation in multiple sclerosis: benefits and risks. | Q35010891 | ||
| Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic autoreactivities | Q35792672 | ||
| Mouse mesenchymal stem cells suppress antigen-specific TH cell immunity independent of indoleamine 2,3-dioxygenase 1 (IDO1). | Q36041377 | ||
| Intense T cell depletion followed by autologous bone marrow transplantation for severe multiple sclerosis | Q36226307 | ||
| Can cell therapy heal a spinal cord injury? | Q37112511 | ||
| CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis | Q37178367 | ||
| Stem cells ameliorate EAE via an indoleamine 2,3-dioxygenase (IDO) mechanism | Q37189921 | ||
| Bone marrow stromal cell therapy reduces proNGF and p75 expression in mice with experimental autoimmune encephalomyelitis | Q37218139 | ||
| Human bone marrow-derived mesenchymal stem cells induce Th2-polarized immune response and promote endogenous repair in animal models of multiple sclerosis. | Q37253314 | ||
| Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms | Q37415917 | ||
| Adult neural stem cells expressing IL-10 confer potent immunomodulation and remyelination in experimental autoimmune encephalitis | Q37452238 | ||
| Current disease-modifying treatment of multiple sclerosis | Q37855719 | ||
| Immune mechanisms underlying the beneficial effects of autologous hematopoietic stem cell transplantation in multiple sclerosis | Q37929621 | ||
| Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis | Q39501938 | ||
| Neuroprotective mesenchymal stem cells are endowed with a potent antioxidant effect in vivo | Q39823115 | ||
| Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis | Q39930711 | ||
| Sarcoma derived from cultured mesenchymal stem cells | Q40220522 | ||
| Serial in vivo MR tracking of magnetically labeled neural spheres transplanted in chronic EAE mice. | Q40257049 | ||
| CNS-targeted LIF expression improves therapeutic efficacy and limits autoimmune-mediated demyelination in a model of multiple sclerosis | Q40295296 | ||
| Cell-based gene therapy experiments in murine experimental autoimmune encephalomyelitis | Q40445781 | ||
| Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. | Q40460778 | ||
| Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study. | Q40637757 | ||
| Different therapeutic outcomes in experimental allergic encephalomyelitis dependent upon the mode of delivery of IL-10: a comparison of the effects of protein, adenoviral or retroviral IL-10 delivery into the central nervous system | Q40822135 | ||
| Repetitive injections of dendritic cells matured with tumor necrosis factor alpha induce antigen-specific protection of mice from autoimmunity. | Q41985283 | ||
| Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis | Q42454885 | ||
| High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience. | Q43115592 | ||
| Human mesenchymal stem cells abrogate experimental allergic encephalomyelitis after intraperitoneal injection, and with sparse CNS infiltration | Q43195511 | ||
| Transplanted myogenic progenitor cells express neuronal markers in the CNS and ameliorate disease in experimental autoimmune encephalomyelitis | Q43274246 | ||
| Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis | Q43831215 | ||
| Dendritic cells exposed to estrogen in vitro exhibit therapeutic effects in ongoing experimental allergic encephalomyelitis | Q45090901 | ||
| Stem cell transplantation: the lung barrier. | Q46028067 | ||
| Immune ablation followed by autologous hematopoietic stem cell transplantation for the treatment of poor prognosis multiple sclerosis | Q46045097 | ||
| Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice | Q46499204 | ||
| Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice | Q46587731 | ||
| Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis | Q46940191 | ||
| Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosis. | Q47586113 | ||
| Magnetic-resonance-based tracking and quantification of intravenously injected neural stem cell accumulation in the brains of mice with experimental multiple sclerosis | Q48122196 | ||
| Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis | Q48227850 | ||
| MR microscopy of magnetically labeled neurospheres transplanted into the Lewis EAE rat brain | Q48275815 | ||
| Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis | Q48276129 | ||
| Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis | Q48332405 | ||
| Bone marrow stromal cells reduce axonal loss in experimental autoimmune encephalomyelitis mice | Q48497239 | ||
| Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells | Q48597221 | ||
| Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis | Q50074143 | ||
| Labeling of Luciferase/eGFP-expressing bone marrow-derived stromal cells with fluorescent micron-sized iron oxide particles improves quantitative and qualitative multimodal imaging of cellular grafts in vivo. | Q50283926 | ||
| Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. | Q50524244 | ||
| Clinical potential of intravenous neural stem cell delivery for treatment of neuroinflammatory disease in mice? | Q50534121 | ||
| Time-dependent fate of transplanted neural precursor cells in experimental autoimmune encephalomyelitis mice. | Q50555364 | ||
| Neuroprotection and immunomodulation with mesenchymal stem cells in chronic experimental autoimmune encephalomyelitis. | Q50632074 | ||
| Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. | Q50767537 | ||
| Prevention of experimental autoimmune encephalomyelitis in DA rats by grafting primary skin fibroblasts engineered to express transforming growth factor-beta1. | Q51641991 | ||
| Spontaneous human adult stem cell transformation. | Q53358878 | ||
| Survival of neural precursor cells in growth factor-poor environment: implications for transplantation in chronic disease. | Q54627067 | ||
| Neural precursor cells inhibit multiple inflammatory signals | Q56900350 | ||
| P433 | issue | 2 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 245-259 | |
| P577 | publication date | 2012-03-01 | |
| P1433 | published in | Regenerative Medicine | Q19921466 |
| P1476 | title | Stem cell therapy for multiple sclerosis: preclinical evidence beyond all doubt? | |
| P478 | volume | 7 |
| Q42208013 | Distinct spatial distribution of microglia and macrophages following mesenchymal stem cell implantation in mouse brain. |
| Q36264901 | In vivo differentiation of induced pluripotent stem cells into neural stem cells by chimera formation. |
| Q34852908 | Injury-dependent retention of intraportally administered mesenchymal stromal cells following partial hepatectomy of steatotic liver does not lead to improved liver recovery |
| Q37576255 | Intraspinal transplantation of mouse and human neural precursor cells |
| Q37585439 | Mesenchymal stromal cells mediate Aspergillus hyphal extract-induced allergic airway inflammation by inhibition of the Th17 signaling pathway. |
| Q42361828 | Metabolic pathways as possible therapeutic targets for progressive multiple sclerosis |
| Q39279957 | Neural Stem Cell-Based Regenerative Approaches for the Treatment of Multiple Sclerosis |
| Q36633053 | Spatiotemporal evolution of early innate immune responses triggered by neural stem cell grafting |
Search more.